Lucid Health Consulting in Mcmahons Point | Business service

Lucid Health Consulting

Locality: Mcmahons Point

Phone: +61 435 934 394

Add/Update information

Reviews

Tags

• Medical and health
• Business service
• Business consultant
• Pharmaceuticals

20.01.2022 A bit belated but a great photo capturing almost all the Lucid Health Consulting team together for our annual end of year Christmas lunch, 2020. We missed our team members in Perth tag Patrick Fitzgerald, San Diego, Steve Duff and India/Singapore, Hemant Rathi and Khavya Ramachandran, who sadly couldn't join us. Here's hoping 2021 brings many more opportunities for the team to connect in person and unite.

19.01.2022 Lucid Health Consulting enters strategic agreement with MAOSS for Australian Market Access Data. Lucid Health Consulting is pleased to announce a strategic partnership agreement with MAOSS effective from 1 October 2020. MAOSS is a unique market access platform, providing a one stop shop for Australian reimbursement data needs.... Using the MAOSS database, organisations looking to enhance the market access and reimbursement for drugs, devices and technologies in the Australian market, have access to: Free Text Search for PBS Items based on generic name, trade name, or indication Instant historical utilization for all current PBS items, for either business analysis or financial impact analysis Access to Ex-Manufacturer and DPMQ/DPMA prices over time And More, All from one single portal. To find out more about the strategic partnership agreement between Lucid Health Consulting and MAOSS, see the full announcement via our website: https://lnkd.in/gB3v-Ss Contact: Lucid Health Consulting email: [email protected] or phone: + 61 2 8964 9600. MAOSS email: [email protected] or phone: +61 413 759 970. Media enquiries: Kim MacDonald, Spindrift Marketing phone +61 402 833 499

12.01.2022 ICER’s Growing Influence on Payer Decision Making: The Impact of ICER Assessments on Market Dynamics and Patient Access

10.01.2022 Lucid Health Consulting (LHC) provides expertise in regulatory services, health economics, health technology assessments, pricing and reimbursement strategy to pharmaceutical, biotech, medical device and diagnostic companies.

09.01.2022 Please join us for this free webinar, hosted by George Papadopoulos our Partner & Director of Lucid Health Consulting and Sarah Griffin, Director of MedTechnique Consulting as they discuss the latest developments in gaining reimbursement in the Australian market. George and Sarah share their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market, as well as answering webinar attendee’s questions. The Drugs & Devices... Australia webinar is always a popular one on the MedTech calendar, register today using the registration link below. Register here for our free 6th Annual Drugs & Devices Australia Reimbursement Update. Webinar registration: https://us02web.zoom.us//tZAsf-Gurj0vHN0cYKgBHgLythei0JlxE After registering, you will receive a confirmation email containing information about joining the meeting.

08.01.2022 ISPOR Vos Research Round Up, January - February 2021 The latest issue of ISPORThe Professional Society for Health Economics and Outcomes Research's Values & Outcomes Spotlight looks at vaccine hesitancy and how this can adversely affect the distribution of the COVID-19 vaccine. Our Director at Lucid Health Consulting, George Papadopoulos, is section editor of the Research Roundup. The articles in this month’s Research Roundup look at the topic of vaccine health economics and... outcomes research (HEOR), including the challenges and opportunities presented by COVID-19, accounting for herd immunity and the value of trust in addressing vaccine hesitancy. Read the full Research Roundup article here: https://lnkd.in/g_XrZZm

05.01.2022 Yesterday our Director George Papadopoulos kicked off the 2021 academic year at UNSW with a lecture on The Pharmaceutical Benefits Scheme, for the Health Technology Assessment course in the Master of Pharmaceutical Medicine degree at the UNSW School of Medical Sciences, Faculty of Medicine. In this course, amongst other areas, students learn about the pricing considerations for ensuring successful applications to the PBAC for entry of medicines on the Pharmaceutical Benefits Scheme (PBS) in Australia. To date 511 have graduated from the Master of Pharmaceutical Medicine degree, over the 25 years that the program has been operating; many of whom have contributed to the development of this industry both in Australia and globally.

04.01.2022 Our Director at Lucid Health Consulting, George Papadopoulos, authored the ISPORThe Professional Society for Health Economics and Outcomes Research, Research Roundup in the November-December 2020 Edition of the Value & Outcomes Spotlight. The articles in this session of Research Roundup look at precision medicine. Precision medicine has held promise for many years as a tailored approach to both disease prevention and treatment that considers the differences in people’s genet...ic makeup. Genomic sequencing underpins the value of precision medicine in being able to better predict, prevent, diagnose, and treat diseases. Whilst there is an abundance of literature on precision medicine, we have tried to identify recent research that encapsulates these characteristics. ISPOR | November/December 2020 Value & Outcomes Spotlight, RESEARCH ROUNDUP. Read the full article: https://lucidhealthcon.com/ispor-vos-research-round-up-nov/

01.01.2022 The Editors have announced the themes that we’ll be covering this year in ISPOR’s Value & Outcomes Spotlight HEOR news magazine. Are you working on a project or initiative that fits one of them? For more information including instructions for authors, visit http://ow.ly/EYFm50DAZL0.